$27.51
+0 (+0%)
At Close: Jun 03, 2026
Hims & Hers: A Platform Strategy Pivot Driving Long-Term Value
10:04am, Friday, 30'th Jan 2026
While the market fixates on short-term product cycles, Hims & Hers (HIMS) is quietly building a healthcare platform, aiming to control the primary interface for diagnostics, prevention, and personaliz
Hims & Hers Returns to the Big Game with a Message to All Americans: The Era of Health as a Luxury is Over
09:00am, Thursday, 29'th Jan 2026
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, announced that it's heading back to the Big Game this year. On Febru
Hims & Hers: It's Time To Get Aggressive
06:15pm, Wednesday, 28'th Jan 2026
Hims & Hers is a Strong Buy, as shares appear historically cheap due to temporary margin compression and regulatory concerns. HIMS's recurring revenue model, 70%+ gross margins, and rapid subscriber g
Hims & Hers Health, Inc. (HIMS) Stock Declines While Market Improves: Some Information for Investors
06:45pm, Tuesday, 27'th Jan 2026
Hims & Hers Health, Inc. (HIMS) reached $29.68 at the closing of the latest trading day, reflecting a -1.98% change compared to its last close.
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?
10:01am, Tuesday, 27'th Jan 2026
Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Telehealth Stock Popular With Bulls Despite Underperformance
03:16pm, Monday, 26'th Jan 2026
Hims & Hers Health Inc (NYSE:HIMS) shares are up 3.4% to trade at $30.60 at last glance.
Hims & Hers Scales Platform-Led Digital Healthcare Access and Care
11:20am, Monday, 26'th Jan 2026
HIMS expands its tech-driven care platform with new diagnostics, AI tools and specialty treatments for personalized health.
Head-To-Head Comparison: Hims & Hers Health (NYSE:HIMS) & Privia Health Group (NASDAQ:PRVA)
01:00am, Monday, 26'th Jan 2026
Privia Health Group (NASDAQ: PRVA - Get Free Report) and Hims and Hers Health (NYSE: HIMS - Get Free Report) are both mid-cap medical companies, but which is the better investment? We will contrast th
Hims & Hers Health: The Reset Nobody Expected
05:00am, Sunday, 25'th Jan 2026
Revenue grew nearly 50% year over year in Q3 2025 to ~$600 million, with ARPU rising and free cash flow reaching $79 million. Gross margin declined to ~74% from high-70s levels due to GLP-1 shipping c
First Look: Capital One (COF) buys Brex; PJM eyes data-center auction
07:37am, Friday, 23'rd Jan 2026
Stock News TikTok sets up U.S. data-security JV: TikTok USDS Joint Venture LLC launched as a majority American-owned entity to safeguard U.S. user data, algorit
HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling?
01:45pm, Thursday, 22'nd Jan 2026
Hims & Hers and Tempus AI are transforming digital health in distinct ways, but which platform looks more compelling right now? Let's dive in.
Emerald Advisers LLC Acquires New Position in Hims & Hers Health, Inc. $HIMS
04:53am, Thursday, 22'nd Jan 2026
Emerald Advisers LLC acquired a new position in shares of Hims and Hers Health, Inc. (NYSE: HIMS) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Com
Critical Survey: Hims & Hers Health (NYSE:HIMS) versus Schrodinger (NASDAQ:SDGR)
01:15am, Thursday, 22'nd Jan 2026
Hims and Hers Health (NYSE: HIMS - Get Free Report) and Schrodinger (NASDAQ: SDGR - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses
2 Top Stocks to Double Up On Right Now
07:05pm, Tuesday, 20'th Jan 2026
Amazon could be on the cusp of an artificial intelligence (AI)-driven boom in profitability. Hims & Hers Health stock is pricey, but the company's massive growth potential makes up for it.
Hims & Hers Expands Platform-Led Access to Digital Healthcare
01:15pm, Monday, 19'th Jan 2026
HIMS leverages a software-driven platform to scale personalized digital care across new health categories and markets.
Sign In
Buy HIMS